Merit Medical Systems, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $6.3 Billion | 6/11 | RMD $34.2B |
COO $17.6B |
WST $15.6B |
ATR $9.6B |
TFX $7.8B |
MMSI $6.3B |
ICUI $3.9B |
NVST $3.7B |
XRAY $3.6B |
HAE $3.1B |
ANGO $418.4M |
Gross Margin | 46% | 8/11 | COO 67% |
RMD 59% |
HAE 56% |
TFX 56% |
ANGO 55% |
NVST 53% |
XRAY 52% |
MMSI 46% |
ATR 39% |
WST 35% |
ICUI 35% |
Profit Margin | 8% | 7/11 | RMD 27% |
WST 18% |
TFX 15% |
COO 12% |
ATR 12% |
HAE 11% |
MMSI 8% |
NVST 1% |
ICUI -6% |
ANGO -15% |
XRAY -52% |
EBITDA margin | 22% | 3/11 | RMD 28% |
ATR 23% |
MMSI 22% |
WST 22% |
COO 19% |
HAE 17% |
TFX 15% |
NVST 10% |
XRAY 7% |
ICUI 1% |
ANGO -3% |
Quarterly Revenue | $339.8 Million | 10/11 | RMD $1.3B |
COO $1.0B |
XRAY $951.0M |
ATR $848.1M |
TFX $764.4M |
WST $746.9M |
NVST $601.0M |
ICUI $589.1M |
HAE $348.5M |
MMSI $339.8M |
ANGO $72.8M |
Quarterly Earnings | $28.4 Million | 7/11 | RMD $344.6M |
WST $136.0M |
COO $117.5M |
TFX $111.0M |
ATR $100.9M |
HAE $37.5M |
MMSI $28.4M |
NVST $8.2M |
ANGO -$10.7M |
ICUI -$33.0M |
XRAY -$494.0M |
Quarterly Free Cash Flow | $37.4 Million | 7/11 | WST $370.9M |
TFX $306.6M |
RMD $289.7M |
ATR $107.7M |
XRAY $98.0M |
NVST $63.3M |
MMSI $37.4M |
HAE $35.2M |
ICUI $21.6M |
ANGO $1.7M |
COO -$0 |
Trailing 4 Quarters Revenue | $1.3 Billion | 10/11 | RMD $4.9B |
ATR $3.6B |
TFX $3.0B |
COO $3.0B |
XRAY $2.9B |
WST $2.9B |
NVST $2.8B |
ICUI $2.3B |
HAE $1.4B |
MMSI $1.3B |
ANGO $286.5M |
Trailing 4 Quarters Earnings | $120.0 Million | 7/11 | RMD $1.3B |
COO $1.0B |
XRAY $951.0M |
ATR $848.1M |
TFX $764.4M |
WST $746.9M |
NVST $601.0M |
ICUI $589.1M |
HAE $348.5M |
MMSI $339.8M |
ANGO $72.8M |
Quarterly Earnings Growth | 10% | 6/11 | RMD 65% |
ANGO 63% |
ATR 62% |
COO 39% |
HAE 20% |
MMSI 10% |
WST -16% |
TFX -19% |
NVST -62% |
XRAY -86% |
ICUI -556% |
Annual Earnings Growth | 39% | 2/11 | RMD 44% |
MMSI 39% |
HAE 23% |
ATR 19% |
COO 15% |
WST -20% |
TFX -50% |
ANGO -307% |
ICUI -392% |
NVST -855% |
XRAY -5900% |
Quarterly Revenue Growth | 8% | 3/11 | RMD 10% |
COO 10% |
MMSI 8% |
ICUI 6% |
HAE 4% |
TFX 2% |
ATR 1% |
XRAY 0% |
WST 0% |
NVST -5% |
ANGO -8% |
Annual Revenue Growth | 4% | 5/11 | RMD 22% |
NVST 7% |
HAE 6% |
ICUI 6% |
MMSI 4% |
TFX 2% |
ATR 2% |
WST -4% |
ANGO -9% |
COO -20% |
XRAY -28% |
Cash On Hand | $523.1 Million | 2/11 | NVST $991.3M |
MMSI $523.1M |
RMD $521.9M |
WST $490.9M |
HAE $320.8M |
ICUI $312.5M |
XRAY $296.0M |
TFX $243.2M |
ATR $223.8M |
COO $107.6M |
ANGO $54.1M |
Short Term Debt | $11.5 Million | 8/11 | XRAY $422.0M |
NVST $115.8M |
TFX $96.9M |
ICUI $51.0M |
RMD $37.7M |
COO $33.3M |
WST $19.9M |
MMSI $11.5M |
HAE $5.1M |
ANGO -$0 |
ATR -$0 |
Long Term Debt | $750.5 Million | 8/11 | COO $2.6B |
XRAY $1.9B |
TFX $1.8B |
ICUI $1.5B |
NVST $1.3B |
HAE $1.2B |
RMD $802.0M |
MMSI $750.5M |
ATR $688.1M |
WST $284.9M |
ANGO $0 |
PE | 52.50 | 1/11 | MMSI 52.50 |
COO 44.82 |
TFX 32.75 |
WST 31.13 |
RMD 27.40 |
ATR 25.71 |
HAE 24.09 |
XRAY -1.00 |
ANGO -1.00 |
ICUI -1.00 |
NVST -1.00 |
PS | 4.75 | 4/11 | RMD 6.95 |
COO 5.93 |
WST 5.41 |
MMSI 4.75 |
ATR 2.69 |
TFX 2.57 |
HAE 2.28 |
ICUI 1.68 |
ANGO 1.46 |
NVST 1.32 |
XRAY 1.25 |
PB | 4.76 | 3/11 | RMD 6.51 |
WST 5.65 |
MMSI 4.76 |
ATR 3.87 |
HAE 3.45 |
ANGO 2.24 |
COO 2.18 |
ICUI 1.91 |
TFX 1.74 |
XRAY 1.46 |
NVST 1.21 |
PC | 12.05 | 8/11 | COO 163.41 |
RMD 65.56 |
ATR 43.01 |
TFX 31.97 |
WST 31.68 |
ICUI 12.55 |
XRAY 12.30 |
MMSI 12.05 |
HAE 9.76 |
ANGO 7.74 |
NVST 3.76 |
Liabilities to Equity | 0.80 | 4/11 | HAE 1.79 |
XRAY 1.66 |
ICUI 1.10 |
MMSI 0.80 |
ATR 0.79 |
NVST 0.79 |
TFX 0.67 |
ANGO 0.56 |
COO 0.52 |
RMD 0.36 |
WST 0.34 |
ROA | 0.05 | 4/11 | RMD 17% | WST 14% | ATR 8% | MMSI 5% | HAE 5% | COO 3% | TFX 3% | ICUI -3% | XRAY -7% | NVST -24% | ANGO -77% |
ROE | 0.09 | 5/11 | RMD 24% |
WST 18% |
ATR 15% |
HAE 14% |
MMSI 9% |
COO 5% |
TFX 5% |
ICUI -5% |
XRAY -19% |
NVST -44% |
ANGO -120% |
Current Ratio | 2.25 | 8/11 | WST 3.98 |
RMD 3.78 |
COO 2.91 |
ANGO 2.78 |
TFX 2.49 |
ATR 2.28 |
NVST 2.26 |
MMSI 2.25 |
ICUI 1.91 |
XRAY 1.60 |
HAE 1.56 |
Quick Ratio | 0.50 | 3/11 | MMSI 52.50 |
COO 44.82 |
TFX 32.75 |
WST 31.13 |
RMD 27.40 |
ATR 25.71 |
HAE 24.09 |
XRAY -1.00 |
ANGO -1.00 |
ICUI -1.00 |
NVST -1.00 |
Long Term Debt to Equity | 0.57 | 4/11 | HAE} 1.35 |
XRAY} 0.76 |
ICUI} 0.75 |
MMSI} 0.57 |
NVST} 0.42 |
TFX} 0.39 |
COO} 0.32 |
ATR} 0.28 |
RMD} 0.15 |
WST} 0.10 |
ANGO} 0.00 |
Debt to Equity | 0.57 | 4/11 | HAE 1.35 |
XRAY 0.93 |
ICUI 0.78 |
MMSI 0.57 |
NVST 0.46 |
TFX 0.42 |
COO 0.32 |
ATR 0.28 |
RMD 0.16 |
WST 0.11 |
ANGO 0.00 |
Burn Rate | 117.73 | 1/11 | MMSI 117.73 |
HAE 25.53 |
NVST 13.58 |
ANGO 5.04 |
ICUI 2.91 |
XRAY 0.44 |
RMD -1.72 |
ATR -3.05 |
WST -4.10 |
TFX -15.01 |
COO -15.03 |
Cash to Cap | 0.08 | 4/11 | NVST 0.27 |
ANGO 0.13 |
HAE 0.10 |
MMSI 0.08 |
XRAY 0.08 |
ICUI 0.08 |
TFX 0.03 |
WST 0.03 |
RMD 0.02 |
ATR 0.02 |
COO 0.01 |
CCR | 1.32 | 4/11 | NVST 7.72 |
TFX 2.76 |
WST 2.73 |
MMSI 1.32 |
ATR 1.07 |
HAE 0.94 |
RMD 0.84 |
ANGO -0.16 |
XRAY -0.20 |
ICUI -0.65 |
COO |
EV to EBITDA | 88.79 | 5/11 | ICUI} 631.77 |
COO} 101.11 |
RMD} 95.35 |
WST} 95.26 |
MMSI} 88.79 |
XRAY} 87.16 |
TFX} 84.69 |
NVST} 70.63 |
HAE} 68.39 |
ATR} 51.78 |
ANGO} -145.27 |
EV to Revenue | 4.93 | 4/11 | RMD 7.01 |
COO 6.77 |
WST 5.34 |
MMSI 4.93 |
TFX 3.10 |
HAE 2.94 |
ATR 2.82 |
ICUI 2.22 |
XRAY 1.95 |
NVST 1.48 |
ANGO 1.27 |